FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

386935009: Tazarotene (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1461113015 Tazarotene (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481049014 Tazarotene en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
368111000195117 tazarotene it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
843771000172116 tazarotène fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tazarotene (substance) Is a Retinoid (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing tazarotene (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tazarotene (substance) Inferred relationship Some 1
Tazarotene 0.1% gel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tazarotene (substance) Inferred relationship Some
Tazarotene 0.05% gel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tazarotene (substance) Inferred relationship Some
Tazarotene 0.05% aqueous gel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tazarotene (substance) Inferred relationship Some
Tazarotene 0.1% aqueous gel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tazarotene (substance) Inferred relationship Some
Tazarotene 0.1% cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tazarotene (substance) Inferred relationship Some
Tazarotene 0.05% cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tazarotene (substance) Inferred relationship Some
Tazarotene 500 microgram/mL cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tazarotene (substance) Inferred relationship Some
Product containing precisely tazarotene 1 milligram/1 milliliter conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tazarotene (substance) Inferred relationship Some
Tazarotene 500 microgram/g cutaneous gel This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Tazarotene (substance) Inferred relationship Some 1
Tazarotene 500 microgram/g cutaneous gel The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tazarotene (substance) Inferred relationship Some 1
Product containing precisely tazarotene 1 milligram/1 gram conventional release cutaneous gel (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Tazarotene (substance) Inferred relationship Some 1
Product containing precisely tazarotene 1 milligram/1 gram conventional release cutaneous gel (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tazarotene (substance) Inferred relationship Some 1
Tazarotene-containing product in cutaneous dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tazarotene (substance) Inferred relationship Some 1
Product containing only tazarotene (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tazarotene (substance) Inferred relationship Some 1
Tazarotene only product in cutaneous dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tazarotene (substance) Inferred relationship Some 1
Tazarotene 500 microgram/mL cutaneous cream This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Tazarotene (substance) Inferred relationship Some 1
Tazarotene 500 microgram/mL cutaneous cream The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tazarotene (substance) Inferred relationship Some 1
Product containing precisely tazarotene 1 milligram/1 milliliter conventional release cutaneous cream (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tazarotene (substance) Inferred relationship Some 1
Product containing precisely tazarotene 1 milligram/1 milliliter conventional release cutaneous cream (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Tazarotene (substance) Inferred relationship Some 1
Product containing halobetasol and tazarotene (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tazarotene (substance) Inferred relationship Some 1
Product containing halobetasol and tazarotene in cutaneous dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tazarotene (substance) Inferred relationship Some 1
Halobetasol and tazarotene only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tazarotene (substance) Inferred relationship Some 1
Product containing only halobetasol and tazarotene in cutaneous dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tazarotene (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start